2025-10-06T12:23:23-05:00 2024-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2024-01-01 522275294 SARCOMA FOUNDATION OF AMERICA SARC 3012538687 9899 MAIN STREET 204 DAMASCUS MD 20872 BRANDI FELSER CEO 3012538687 2025-10-03 1 1 MARK C THOMAS P00362982 3019860600 2025-10-03 2024 2025-03-06 01:10:19Z BRANDI FELSER 9899 MAIN STREET 204 DAMASCUS MD 20872 6880480 0 X WWW.CURESARCOMA.ORG X 2000 MD WE ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH, INCREASING AWARENESS, & PROVIDING PATIENT EDUCATION. 9 9 19 107 0 0 3689910 3185724 20000 70000 192208 451436 -192866 -159258 3709252 3547902 995248 934210 0 0 1601379 1764175 0 0 345515 625811 872237 3222438 3570622 486814 -22720 11153810 11423128 648297 398808 10505513 11024320 X THE MISSION OF THE ORGANIZATION IS TO ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH AND BY INCREASING AWARENESS ABOUT THE DISEASE. THE ORGANIZATION RAISES MONEY TO PRIVATELY FUND GRANTS FOR SARCOMA RESEARCHERS AND CONDUCTS EDUCATION AND ADVOCACY EFFORTS ON BEHALF OF SARCOMA PATIENTS. 0 0 2695788 934210 99727 THE SARCOMA FOUNDATION OF AMERICA (SFA) COORDINATES A NATIONAL RESEARCH GRANT PROGRAM THAT FUNDS TRANSLATIONAL SCIENCE SARCOMA RESEARCH. IN ACCORDANCE WITH THE MISSION OF THE SFA, RESEARCH INVOLVING THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, OR RESEARCH THAT COULD POTENTIALLY LEAD TO THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, IS SUPPORTED THROUGH THIS FUNDING. THE SFA ENGAGES IN PATIENT EDUCATION PROGRAMS ON THE LATEST DEVELOPMENTS IN SARCOMA RESEARCH AND TREATMENTS. THESE EDUCATION INITIATIVES ARE DESIGNED TO FURTHER STRENGTHEN AND DEEPEN PATIENTS' ABILITY TO PARTICIPATE IN THEIR CARE AND RESEARCH PROJECTS. SFA ALSO CONDUCTS ADVOCACY ACTIVITIES ON BEHALF OF THE SARCOMA COMMUNITY TO ENSURE ADEQUATE FEDERAL CANCER RESEARCH FUNDING LEVELS AND POLICIES THAT POSITIVELY IMPACT SARCOMA PATIENTS. 2695788 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 34 0 1 19 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA CT FL GA IL KY MA MD MI MN NC NJ NY OR PA SC VA TN WV WI MS AR HI KS NH NM AK CO ME OH OK WA X X THE ORGANIZATION 3012538687 9899 MAIN STREET 204 DAMASCUS MD 20872 MARK THORNTON MD PHD PRESIDENT 3.00 X X 0 0 0 JOHN SJ BROOKS MD VICE PRESIDENT 1.00 X X 0 0 0 PATRICIA THORNTON TREASURER 3.00 X X 0 0 0 CHRISTOPHER CONNERY DIRECTOR 1.00 X 0 0 0 MICHAEL LEWIS DIRECTOR 1.00 X 0 0 0 JUSTIN GREEN DIRECTOR 1.00 X 0 0 0 BRUCE MARCH DIRECTOR 1.00 X 0 0 0 JENNIFER GOODWIN SECRETARY 1.00 X X 0 0 0 JENNIFER NELLANY DIRECTOR 1.00 X 0 0 0 BRANDI CLEARY-FELSER CEO 40.00 X 219241 0 22049 DEAN FROHLICH DIRECTOR OF SCIENTIFIC AFFAIRS 40.00 X 152541 0 14964 ANNIE BLAKE NATIONAL DIRECTOR, RTCS 40.00 X 104885 0 17335 476667 0 54348 3 0 1 0 ROSE GROUP PARK AVENUE LLC 583 PARK AVENUE NEW YORK NY 10065 EVENT SPACE RENTAL 109833 1 13170 1061301 2111253 78342 3185724 EDUCATIONAL EVENTS 900099 70000 70000 70000 291686 291686 2864676 2704926 159750 159750 159750 438667 1061301 627652 -188985 -188985 MISCELLANEOUS REVENUE 900099 29727 29727 29727 3547902 99727 0 262451 527057 527057 7153 7153 400000 400000 241290 169751 42169 29370 1222624 860131 213674 148819 48488 34112 8474 5902 144065 101351 25178 17536 107708 75774 18824 13110 9465 6659 1654 1152 47483 47483 43349 43349 165620 83571 42993 39056 32600 23586 5313 3701 91313 61662 13797 15854 231688 164589 39552 27547 82648 58144 14444 10060 3685 3685 90820 62948 321 27551 22661 15942 3961 2758 11617 8173 2030 1414 DUES AND SUBSCRIPTIONS 15445 15445 REGISTRATION FEES 12925 9093 2259 1573 SPONSORSHIP 10000 10000 MISCELLANEOUS 918 647 159 112 3570622 2695788 529319 345515 X 17588 13757 1897 1934 685352 1264566 793929 446566 190921 124126 143442 60725 236685 161702 53446 74983 9118100 9343301 168620 108861 11153810 11423128 253251 233287 204248 57035 190798 108486 648297 398808 X 8554729 8954255 1950784 2070065 10505513 11024320 11153810 11423128 -22720 541527 0 X X 0 1 X 1 0 X 2294899 3432529 3559687 3689910 3185724 16162749 266795 270951 346957 20000 70000 974703 2561694 3703480 3906644 3709910 3255724 17137452 0 0 0 17137452 112890 97262 125558 207691 291686 835087 112890 97262 125558 207691 291686 835087 398 664 641 184 29727 31614 2674982 3801406 4032843 3917785 3577137 18004153 0.95190 0.96300 0.04640 0.03610 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3680 3680 3566942 3570622 328531 82133 0 0 269828 284507 311122 328531 1193988 1790982 511 861 346 3680 5398 67457 71127 77781 82133 298498 447747 1056802 25000 188557 1270359 905220 25000 126582 1056802 892197 140000 -126977 905220 705148 90000 97049 892197 507777 135245 62126 705148 0.80890 0.13300 0.05810 0 0 78190 60088 18102 77187 59089 18098 81308 42525 38783 74983 OPERATING LEASE LIABILITY 108486 108486 X 4291190 541527 56125 188985 786637 3504553 43349 43349 3547902 3772383 56125 188985 245110 3527273 43349 43349 3570622 PART X, LINE 2: INCOME TAXES NO PROVISION HAS BEEN MADE FOR INCOME TAXES, SINCE THE ORGANIZATION HAS BEEN DETERMINED TO BE EXEMPT FROM INCOME TAX PURSUANT TO INTERNAL REVENUE CODE SECTION 501(C)(3). THERE WAS NO NET UNRELATED BUSINESS TAXABLE INCOME DURING THE YEAR. THE ORGANIZATION ADOPTED THE FINANCIAL ACCOUNTING STANDARDS BOARD FASB ASC 740-10, INCOME TAXES, WHICH REQUIRES AN ASSESSMENT OF UNCERTAINTY IN INCOME TAXES AND CERTAIN FINANCIAL STATEMENT DISCLOSURES RELATING TO UNRECOGNIZED TAX BENEFITS. FOR THE YEAR ENDED DECEMBER 31, 2024, THE ORGANIZATION HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS EXIST REQUIRING EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. NO RETURNS ARE CURRENTLY UNDER EXAMINATION. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE 188,985. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE 188,985. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES CANCER RESEARCH 300000 NORTH AMERICA 0 0 PROGRAM SERVICES CANCER RESEARCH 100000 0 0 0 0 0 0 400000 0 400000 CANADA GRANT - TIRATH FAMILY RESEARCH AWARD 50000 0 CANADA GRANT - DON HARP MEMORIAL RESEARCH AWARD - POUL SORENSEN, MD, PHD 50000 0 FRANCE GRANT - JAY VERNON JACKSON MEMORIAL RESEARCH AWARD 50000 0 IRELAND GRANT - RICHARD AND VALERIE ARONSOHN MEMORIAL RESEARCH AWARD 150000 0 IRELAND GRANT - SARCOMA FOUNDATION OF AMERICA RESEARCH AWARD 50000 0 NETHERLANDS GRANT - CHRIS LANGBEIN MEMORIAL RESEARCH AWARD 50000 0 0 6 0 0 0 0 0 0 PART I, LINE 2: GRANTEES ARE REQUIRED TO PROVIDE FINAL SCIENTIFIC REPORT AND FINAL FINANCIAL REPORT AFTER THE CONCLUSION OF THE ONE-YEAR GRANT PERIOD. GALA 346793 190253 156540 6816 109833 28500 94171 OTHER EVENTS 1153175 871048 282127 21343 34127 10972 13308 308582 1499968 1061301 438667 28159 143960 10972 41808 402753 627652 -188985 1 CLEVELAND CLINIC PHILANTHROPY INSTITUTE PO BOX 931517 CLEVELAND OH 441931655 340714585 501C (3) 57035 0 TO SUPPORT SARCOMA RESEARCH CLEVELAND CLINIC FOUNDATION PO BOX 931517 CLEVELAND OH 441931655 340714585 501C (3) 50000 0 RICHARD AND VALERIE ARONSOHN MEMORIAL RESEARCH AWARD OLD DOMINION UNIVERSITY RESEARCH FOUNDATION PO BOX 6369 NORFOLK VA 23508 546068198 501C (3) 50000 0 JOHN O'BRIEN MEMORIAL RESEARCH AWARD JOHNS HOPKINS UNIVERSITY 12529 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 520595110 501C (3) 50000 0 2023 GIVING TUESDAY DONORS RESEARCH AWARD UNIV OF TX MD ANDERSON CANCER CENTER PO BOX 4266 HOUSTON TX 772104266 746001118 IRS SECTION 170(A) 50000 0 STEVEN VANOVER MEMORIAL RESEARCH AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 1125 MURPHY HALL 405 HILGARD AVE LOS ANGELES CA 900957089 132949483 501C (3) 50000 0 TECHNOBLADE MEMORIAL RESEARCH AWARD THE REGENTS OF THE UNIVERSITY OF COLORADO 12700 EAST 19TH AVE MAIL STOP B139 AURORA CO 80045 846000555 501C (3) 50000 0 BEN TOLKAN MEMORIAL AWARD DANA-FARBER CANCER INSTITUTE INC PO BOX 412846 BOSTON MA 022412846 040263040 501C (3) 50000 0 SARCOMA FOUNDATION OF AMERICA RESEARCH AWARD MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 554860334 416011702 501C (3) 50000 0 MICHAEL PEDRICK MEMORIAL RESEARCH AWARD UM BOARD OF REGENTS (UNIV MICHIGAN SPORE) 1500 E MEDICAL CENTER DR ROGEL CANCER CENTER 4316 ANN ARBOR MI 481095936 386006309 501C (3) 40000 0 NIH - GENETICS, GENOMICS OF LEIOMYOSARCOMA - DIAGNOSIS, TREATMENT - YEAR 2 ASSOCIATION OF CANCER CARE CENTERS 1801 RESEARCH BOULEVARD SUITE 400 ROCKVILLE MD 20850 510137807 501C (3) 30000 0 PROJECT CMA-24-ED00731 - SFA AND ACC EDUCATION AND RESOURCES 11 11 JORDAN'S DREAM FUND - AWARD FOR CLINICAL TRIALS 1 7153 PART I, LINE 2: APPLICANTS FOR SFA GRANTS MUST SUBMIT AN APPLICATION OUTLINING THEIR PROPOSED RESEARCH PROJECT ALONG WITH A DETAILED BUDGET THAT DEMONSTRATES HOW THE AWARD MONEY IS TO BE USED. APPLICANTS ARE MADE AWARE THAT A REQUIREMENT OF THE ACCEPTANCE OF GRANT MONEY IS THAT A FINAL REPORT WILL BE SUBMITTED TO SFA AT THE END OF THE ONE-YEAR GRANT PERIOD. THE FINAL REPORT AND BUDGET IS DUE TO SFA BY JULY 31ST OF THE YEAR AFTER THE AWARD IS MADE. FINAL REPORTS ARE TO CONTAIN INFORMATION ON HOW THE RESEARCH PROGRESSES AND IT MUST BE SIGNED BY BOTH THE PRIMARY INVESTIGATOR AS WELL AS THEIR DEPARTMENT CHAIR. X X X X 0 0 0 0 0 0 0 0 0 BRANDI CLEARY-FELSER CEO 199241 0 20000 0 0 0 8843 0 13206 0 241290 0 0 0 DEAN FROHLICH DIRECTOR OF SCIENTIFIC AFFAIRS 151541 0 1000 0 0 0 6165 0 8799 0 167505 0 0 0 X 6 78342 FAIR MARKET VALUE 0 0 0 PART I, COLUMN (B): REPORTING IN PART I, COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE DIRECTOR OF FINANCE AND ADMINISTRATION, TREASURER AND CEO REVIEW THE 990 BASED ON THE FINANCIAL RECORDS, POLICIES AND PROGRAMS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 12C AT LEAST ONCE A YEAR, OFFICERS ACTING ON BEHALF OF THE SARCOMA FOUNDATION OF AMERICA, INC., SHALL EXECUTE AND SUBMIT A STATEMENT TO THE PRESIDENT DISCLOSING ALL MATERIAL FACTS CONCERNING ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST OR CONFIRMING THAT THERE ARE NO SUCH CONFLICTS TO BE DISCLOSED FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS HAS AN APPOINTED COMPENSATION COMMITTEE THAT ON AN ANNUAL BASIS, REVIEWS AND RECOMMENDS TO THE BOARD THE SALARY OF THE CEO USING CURRENT ECONOMIC DATA FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE AS WELL AS UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED EITHER ITS OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR.